April 2018 FDA Recall Drug by Dr. Reddy's Laboratories, Inc.
D-0727-2018 - Presence of Foreign Tablets/Capsules

This Class II drug recall was voluntarily initiated by Dr. Reddy's Laboratories, Inc. on April 23, 2018 for the product Drug. The FDA reported the reason for recall as presence of foreign tablets/capsules. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-0727-2018

Reason for Recall
Presence of Foreign Tablets/Capsules: One foreign tablet identified as Clopidogrel 75 mg was found in a 100 count bottle of Metoprolol Succiante Extended-Release Tablets.
Initiated
04-23-2018
Reported
05-16-2018
Quantity
8160 bottles

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Dr. Reddy's Laboratories, Inc.
Metoprolol Succinate Extended-Release Tablets, USP, 100 mg, 100 Tablets bottle, Rx only, Manufactured by: Dr. Reddy's Laboratories Limited Bachupally-500 090 India\ NDC 55111-468-01

Batch or Lot Expiration Information

Batch# C706254, 08/2019